Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats

被引:115
作者
Cahill, PA [1 ]
Redmond, EM [1 ]
Hodges, R [1 ]
Zhang, SM [1 ]
Sitzmann, JV [1 ]
机构
[1] JOHNS HOPKINS MED INST,DEPT SURG,BALTIMORE,MD 21205
关键词
nitric oxide synthase; portal hypertension; splanchic hyperemia;
D O I
10.1016/S0168-8278(96)80124-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aim: Portal hypertension is characterized by splanchnic hyperemia due to a reduction in mesenteric vascular resistance. Mediators of this hyperemia include nitric oxide, This is based on several reports indicating a marked splanchnic hyporesponsiveness in portal hyper tension to vasoconstrictor stimuli both in vitro and in vivo, and a subsequent reversal using specific inhibitors of nitric oxide synthase, The objective of this study was to determine firstly whether the functional activity and/or expression of nitric oxide synthase is altered in portal hypertensive vasculature and secondly which isoenzyme form was responsible for the preferential response to nitric oxide blockade in these animals, Methods: We compared nitric oxide synthase functional activity in the hyperemic vasculature of sham and portal hypertensive rats (folio wing partial portal vein ligation), Nitric oxide synthase activities were determined by measuring the conversion of L-arginine to citrulline using ion-exchange chromotagraphy and the amount of immunodetectable nitric oxide synthase in sham and portal hypertensive vessels was determined by Western blot, Results: Ca2+-dependent nitric oxide synthase activity was significantly elevated (p<0.05) in portal hypertensive particulate fractions from the superior mesenteric artery, thoracic aorta and portal vein, Vascular tissue cGMP levels and plasma nitrite levels were both significantly elevated in portal hypertension, Immunodetection with specific antisera raised against the inducible nitric oxide synthase demonstrated a lack of induction within the hyperemic vasculature, Immunodetection with antisera against endothelial nitric oxide synthase showed a significant increase in portal hypertensive portal vein only. These results demonstrate enhanced calcium-dependent nitric oxide synthase activity in portal hypertension hyperemic vessels concurrent with elevated tissue cGMP levels, Conclusion: We conclude that enhanced endothelial nitric oxide synthesis may in part contribute to the hyperdynamic circulation of portal hypertension.
引用
收藏
页码:370 / 378
页数:9
相关论文
共 58 条
  • [1] ARNAL JF, 1994, CIRCULATION, V90, pA2178
  • [2] HEPATIC CIRCULATION - POTENTIAL FOR THERAPEUTIC INTERVENTION
    BALLET, F
    [J]. PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) : 281 - 328
  • [3] ROLE OF GLUCAGON IN SPLANCHNIC HYPEREMIA OF CHRONIC PORTAL-HYPERTENSION
    BENOIT, JN
    ZIMMERMAN, B
    PREMEN, AJ
    GO, VLW
    GRANGER, DN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (05): : G674 - G677
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] ISOLATION OF NITRIC-OXIDE SYNTHETASE, A CALMODULIN-REQUIRING ENZYME
    BREDT, DS
    SNYDER, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) : 682 - 685
  • [6] CLONED AND EXPRESSED NITRIC-OXIDE SYNTHASE STRUCTURALLY RESEMBLES CYTOCHROME-P-450 REDUCTASE
    BREDT, DS
    HWANG, PM
    GLATT, CE
    LOWENSTEIN, C
    REED, RR
    SNYDER, SH
    [J]. NATURE, 1991, 351 (6329) : 714 - 718
  • [7] BRODDE OE, 1992, J HYPERTENS, V10, pS133
  • [8] SHEAR-STRESS INDUCED RELEASE OF NITRIC-OXIDE FROM ENDOTHELIAL-CELLS GROWN ON BEADS
    BUGA, GM
    GOLD, ME
    FUKUTO, JM
    IGNARRO, LJ
    [J]. HYPERTENSION, 1991, 17 (02) : 187 - 193
  • [9] ENHANCED NITRIC-OXIDE SYNTHASE ACTIVITY IN PORTAL HYPERTENSIVE RABBITS
    CAHILL, PA
    FOSTER, G
    REDMOND, EM
    GINGALEWSKI, C
    WU, YP
    SITZMANN, JV
    [J]. HEPATOLOGY, 1995, 22 (02) : 598 - 606
  • [10] NITRIC-OXIDE REGULATES ANGIOTENSIN-II RECEPTORS IN VASCULAR SMOOTH-MUSCLE CELLS
    CAHILL, PA
    REDMOND, EM
    FOSTER, C
    SITZMANN, JV
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 288 (02): : 219 - 229